<DOC>
	<DOC>NCT00294593</DOC>
	<brief_summary>The purpose of this study is to determine whether folinic acid can improve developmental quotient of young Down syndrome patients, given that these present signs of folate deficiency which are known to cause reversible neurological, psychiatric and cognitive disorders.</brief_summary>
	<brief_title>Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>Down syndrome without mosaicism age 3 to 30 months weight over 4 kg possible assessment by the revised BrunetLezine scale history of leukemia West syndrome or nonstable epilepsy nonstable thyroxin treatment</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>30 Months</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Down syndrome</keyword>
	<keyword>folinic acid therapy</keyword>
	<keyword>cognitive functions</keyword>
</DOC>